Challenges to vaccinating adolescents: Vaccine implementation issues

Pediatric Infectious Disease Journal

Volumn 24, Issue 6 SUPPL., 2005, Pages

  Humiston, Sharon G ^a,c   Rosenthal, Susan L ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c Box 655 ^*  (United States)

Author keywords

Adolescents; Immunization; Tdap; Vaccination

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS B VACCINE; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE;

ADOLESCENCE; ADOLESCENT; COST BENEFIT ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEPATITIS B; HUMAN; IMMUNIZATION; MEASLES; MUMPS; PERTUSSIS; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVACCINATION; REVIEW; RUBELLA; VACCINATION;

ADOLESCENT; ADOLESCENT MEDICINE; ADULT; AGE FACTORS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; VACCINATION; WHOOPING COUGH;

EID: 20544439158     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000166161.12087.94     Document Type: Review

References (50)

1. Liu M, Acres B, Balloul JM, et al. Gene-based vaccines and immunotherapeutics. Proc Natl Acad Sci USA. 2004;101(suppl 2):14567-14571.
2. Centers for Disease Control and Prevention. ACIP recommends meningococcal vaccine for adolescents and college freshmen. Available at: http://www.cdc.gov/nip/vaccine/meningitis/mcv4/mcv4-acip. htm. Accessed February 16, 2005.
3. Centers for Disease Control and Prevention. Pertussis Surveillance Report -11/16/04. Bacterial Vaccine-Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention, 2004.
4. Centers for Disease Control and Prevention. Pertussis Surveillance Report: 8/6/04. Bacterial Vaccine-Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention, 2004.
5. Centers for Disease Control and Prevention. Pertussis Surveillance Report -10/17/03. Bacterial Vaccine-Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention, 2003.
6. Centers for Disease Control and Prevention. Pertussis Surveillance Report -9/5/02. Bacterial Vaccine-Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention, 2002.
7. Centers for Disease Control and Prevention. Pertussis Surveillance Report -10/12/01. Bacterial Vaccine-Preventable Disease Branch, National Immunization Program, Centers for Disease Control and Prevention, 2001.
8. Centers for Disease Control and Prevention. Pertussis - United States, 1997-2000. MMWR 2002;51:73-76.
9. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23:985-989.
10. Weithorn LA, Campbell SB. The competency of children and adolescents to make informed treatment decisions. Child Dev. 1982;53:1589-1598.
11. Rosenthal SL, Kottenhahn RK, Biro FM, Succop PA. Hepatitis B vaccine acceptance among adolescents and their parents. J Adolesc Health. 1995;17:248-254.
12. Boehner CW, Howe SR, Bernstein DI, Rosenthal SL. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis. 2003;30:774-778.
13. Rosenthal SL, Lewis LM, Succop PA, Bernstein DI, Stanberry LR. College students' attitudes regarding vaccination to prevent genital herpes. Sex Transm Dis. 1999;26:438-443.
14. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med. 2004;58: 1405-1413.
15. Middleman AB, Guajardo AD, Sunwoo E, Sansaricq KM. Parent knowledge and attitudes about school-based hepatitis B immunization programs. J Sch Health. 2002;72:348-351.
16. Woodwell DA, Cherry DK. National Ambulatory Medical Care Survey: 2002 Summary. Advance Data from Vital and Health Statistics; no 346. Hyattsville, MD: National Center for Health Statistics, 2004.
17. Cassidy WM, Watson B, Ioli VA, Williams K, Bird S, West DJ. A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics. 2001;107:626-631.
18. Deeks SL, Johnson IL. Vaccine coverage during a school-based hepatitis B immunization program. Can J Public Health. 1998;89:98-101.
19. Franzini L, Marks E, Cromwell PF, et al. Projected economic costs due to health consequences of teenagers' loss of confidentiality in obtaining reproductive healthcare services in Texas. Arch Pediatr Adolesc Med. 2004;158:1140-1146.
20. Gordon TE, Zook EG, Averhoff FM, Williams WW. Consent for adolescent vaccination: issues and current practices. J Sch Health. 1997;67:259-264.
21. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States: need for alternative vaccination strategies. JAMA. 1990;263:1218-1222.
22. Centers for Disease Control and Prevention. Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR. 1990;39(RR-2):1-26.
23. Carande-Kulis VG, Maciosek MV, Briss PA, et al. Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med. 2000;18(1 suppl):75-91.
24. Briss PA, Rodewald LE, Hinman AR, S. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. Am J Prev Med. 2000;18(1 suppl 1):97-140.
25. Centers for Disease Control and Prevention. Vaccine-preventable diseases: improving vaccination coverage in children, adolescents, and adults. A report on recommendations from the Task Force on Community Preventive Services. MMWR 1999;48(RR-8):1-15.
26. Schaffer SJ, Humiston SG, Shone LP, et al. Adolescent immunization practices: a national survey of US physicians. Arch Pediatr Adolesc Med. 2001;155:566-571.
27. National Vaccine Advisory Committee. Strategies to sustain success in childhood immunizations. JAMA. 1999;282:363-370.
28. Szilagyi PG, Humiston SG, Pollard Shone L, Kolasa MS, Rodewald LE. Decline in physician referrals to health department clinics for immunizations: the role of vaccine financing. Am J Prev Med. 2000;18:318-324.
29. Berge JJ, Drennan DP, Jacobs RJ, et al. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology. 2000;31:469-473.
30. Zhou F, Reef S, Massoudi M, et al. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States. J Infect Dis. 2004;189(suppl 1):S131-S145.
31. Lieu TA, Thompson KM, Prosser LA, et al. Emerging issues in vaccine economics: perspectives from the USA. Expert Rev Vaccines. 2002;1: 433-442.
32. Iskedjian M, Walker JH, Hemels ME. Economic evaluation of an extended acellular pertussis vaccine programme for adolescents in Ontario, Canada. Vaccine. 2004;22:4215-4227.
33. Ward JI, Hay JW. Cost effectiveness of vaccination against pertussis in adolescence: current considerations. Pediatr Infect Dis J. In press.
34. Sutton's law [MedicineNet web site]. Available at http://www.medterms. com/script/main/art.asp?articlekey=39253. Accessed December 1, 2004.
35. Cassidy WM. School-based adolescent hepatitis B vaccination. J La State Med Soc. 1999;151:622-6.
36. Cassidy W. School-based adolescent hepatitis B immunization programs in the United States: strategies and successes. Pediatr Infect Dis J. 1998;17(suppl):S43-S46.
37. Boyer-Chuanroong L, Woodruff BA, Unti LM, Sumida YU. Immunizations from ground zero: lessons learned in urban middle schools. J Sch Health. 1997;67:269-272.
38. Molliconi SA, Zink T. Managed care organizations and public health: exploring collaboration on adolescent immunizations. J Sch Health. 1997;67:286-289.
39. Middleman AB. Race/ethnicity and gender disparities in the utilization of a school-based hepatitis B immunization initiative. J Adolesc Health. 2004;34:414-419.
40. Bordley WC, Chelminski A, Margolis PA, Kraus R, Szilagyi PG, Vann JJ. The effect of audit and feedback on immunization delivery: a systematic review. Am J Prev Med. 2000;18:343-350.
41. Coyle CM, Currie BP. Improving the rates of inpatient pneumococcal vaccination: impact of standing orders versus computerized reminders to physicians. Infect Control Hosp Epidemiol. 2004;25:904-907.
42. Szilagyi PG, Bordley C, Vann JC, et al. Effect of patient reminder/recall interventions on immunization rates: a review. JAMA. 2000;284:1820-1827.
43. Oster NV, McPhillips-Tangum CA, Averhoff F, Howell K. Barriers to adolescent immunization: a survey of family physicians and pediatricians. J Am Board Fam Pract. 2005;18:13-19.
44. Davis TC, Bocchini JA Jr., Fredrickson D, et al. Parent comprehension of polio vaccine information pamphlets. Pediatrics. 1996;97:804-810.
45. Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papillomavirus vaccine in young women. Int J STD AIDS. 2003;14:300-306.
46. Mays RM, Zimet GD. Recommending STI vaccination to parents of adolescents: the attitudes of nurse practitioners. Sex Transm Dis. 2004; 31:428-432.
47. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med. 2005;159:132-137.
48. Averhoff F, Linton L, Peddecord KM, Edwards C, Wang W, Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health. 2004; 94:978-984.
49. Fogarty KJ, Massoudi MS, Gallo W, et al. Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000. Public Health Rep. 2004;119:163-169.
50. Centers for Disease Control and Prevention. Recommended childhood and adolescent immunization schedule -United States, 2005. MMWR 2005;53:Q1-Q3.